jrnl6179

Publication Venue For

  • Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.  54:2039-2053. 2019
  • FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.  54:1221-1232. 2019
  • Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line.  54:1481-1495. 2019
  • Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.  47:1084-1096. 2015
  • Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.  46:1079-1088. 2015
  • GLI1 upregulates C-JUN through a specific 130-kDa isoform..  44:655-661. 2014
  • GLI1 upregulates C-JUN through a specific 130-kDa isoform.  44:655-661. 2014
  • The anticancer effect and mechanism of α-hederin on breast cancer cells.  45:757-763. 2014
  • The role of Src family kinases in growth and migration of glioma stem cells.  45:302-310. 2014
  • Apolipoprotein e gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis.  43:1002-1010. 2013
  • Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERá signaling.  40:1986-1994. 2012
  • Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells.  39:797-804. 2011
  • Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.  39:373-381. 2011
  • Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.  39:111-119. 2011
  • CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.  38:1279-1285. 2011
  • High Cks1 expression in transgenic and carcinogeninitiated mammary tumors is not always accompanied by reduction in p27Kip1.  34:1425-1431. 2009
  • Protein kinase a serves as a primary pathway in activation of Nur77 expression by gonadotropin-releasing hormone in the LβT2 mouse pituitary gonadotroph tumor cell line.  33:1055-1064. 2008
  • Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience.  33:239-244. 2008
  • Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.  32:1179-1188. 2008
  • Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying α-L-fucose moieties.  32:797-807. 2008
  • Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.  32:625-631. 2008
  • Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.  31:1213-1222. 2007
  • Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.  31:843-850. 2007
  • Variability of in situ proteomic profiling and implications for study design in colorectal tumors.  31:103-111. 2007
  • The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.  30:641-650. 2007
  • MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors.  29:1573-1580. 2006
  • Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma.  29:1319-1329. 2006
  • Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines.  29:665-672. 2006
  • Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.  27:237-246. 2005
  • CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia 2005
  • DNA topoisomerase IIalpha and Her-2/neu gene dosages in pediatric malignant gliomas..  26:1187-1192. 2005
  • Anti-angiogenic gene therapy for cancer (review)..  25:335-343. 2004
  • EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis..  24:703-710. 2004
  • Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study..  25:143-151. 2004
  • Single-chain antibodies: A therapeutic modality for cancer gene therapy (review)..  24:765-771. 2004
  • Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review)..  23:857-869. 2003
  • Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461..  21:1041-1051. 2002
  • Green tea polyphenolic antioxidants and skin photoprotection (Review)..  18:1307-1313. 2001
  • Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.  14:799-806. 1999
  • Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme..  15:481-486. 1999
  • Antitumor activity and pharmacokinetics following oral administration of natural product DNA topoisomerase I inhibitors 10-hydroxycamptothecin and camptothecin in SCID mice bearing human breast cancer xenografts.  10:1147-1156. 1997
  • Development of a metastatic model for human endometrial carcinoma using orthotopic implantation in nude mice.  4:1163-1171. 1994
  • Bomirski melanomas: A versatile and powerful model for pigment cell and melanoma research. (Review).  2:221-228. 1993